메뉴 건너뛰기




Volumn 18, Issue 12, 2013, Pages 747-749

KHA-CARI Guideline: Use of iron in chronic kidney disease patients

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; FERRITIN; IRON; TRANSFERRIN; ANTIANEMIC AGENT; HEMOGLOBIN;

EID: 84888862256     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12139     Document Type: Article
Times cited : (21)

References (6)
  • 1
    • 70949108082 scopus 로고    scopus 로고
    • A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
    • Pfeffer MA, Burdmann EA, Chen C-Y, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N. Engl. J. Med. 2009; 361: 2019-2032.
    • (2009) N. Engl. J. Med. , vol.361 , pp. 2019-2032
    • Pfeffer, M.A.1    Burdmann, E.A.2    Chen, C.-Y.3
  • 2
    • 74049147875 scopus 로고    scopus 로고
    • Hemoglobin variability in patients with chronic kidney disease in the Netherlands
    • van der Putten K, van der Baan FH, Schellekens H, et al. Hemoglobin variability in patients with chronic kidney disease in the Netherlands. Int. J. Artif. Organs 2009; 32: 787-793.
    • (2009) Int. J. Artif. Organs , vol.32 , pp. 787-793
    • Van Der Putten, K.1    Van Der Baan, F.H.2    Schellekens, H.3
  • 3
    • 0036154114 scopus 로고    scopus 로고
    • Epidemiology of anemia associated with chronic renal insufficiency among adults in the united states: Results from the third national health and nutrition examination survey
    • Hsu C-, McCulloch CE, Curhan GC,. Epidemiology of anemia associated with chronic renal insufficiency among adults in the united states: Results from the third national health and nutrition examination survey. J. Am. Soc Nephrol. 2002; 13: 504-510.
    • (2002) J. Am. Soc Nephrol. , vol.13 , pp. 504-510
    • Hsu, C.1    McCulloch, C.E.2    Curhan, G.C.3
  • 4
    • 60149091852 scopus 로고    scopus 로고
    • Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients
    • Kalantar-Zadeh K, Lee GH, Miller JE, et al. Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients. Am. J. Kidney Dis. 2009; 53: 823-834.
    • (2009) Am. J. Kidney Dis. , vol.53 , pp. 823-834
    • Kalantar-Zadeh, K.1    Lee, G.H.2    Miller, J.E.3
  • 5
    • 77749282884 scopus 로고    scopus 로고
    • Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease?
    • Stancu S, Bârsan L, Stanciu A, et al. Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease? Clin. J. Am. Soc. Nephrol. 2010; 5: 409-416.
    • (2010) Clin. J. Am. Soc. Nephrol. , vol.5 , pp. 409-416
    • Stancu, S.1    Bârsan, L.2    Stanciu, A.3
  • 6
    • 84862649343 scopus 로고    scopus 로고
    • Parenteral versus oral iron therapy for adults and children with chronic kidney disease
    • Albaramki J, Hodson EM, Craig JC, et al. Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Cochrane Database Syst. Rev. 2012; (1): Cd007857.
    • (2012) Cochrane Database Syst. Rev. , Issue.1
    • Albaramki, J.1    Hodson, E.M.2    Craig, J.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.